Companies: 10,795·Total market cap: $144.5T

Agentix Corp.

Agentix Corp.

AGTXOTCHealthcare● Active

$0.02

+$0.00(+0.00%)

Market Cap$841406

P/E Ratio—

52W High$0.055

52W Low$0.0165

Avg Volume3K

Open$0.04

Beta0.70

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Agentix Corp.（AGTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · AGTX · 截至 Jun 15, 2026

关键指标

EPS (TTM)$-0.01Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding40.1MShares outstanding history

Next EarningsTBAEarnings history

探索 Agentix Corp. 数据

分析师预测—

股息不分红

盈利EPS $-0.01+59.43%

财务快照

FY 2025Revenue$0.00

202120232025

FY 2025Net Income-$567048.00▲ +58.72% YoY

202120232025

FY 2025EPS$-0.01▲ +59.43% YoY

202120232025

TTM:Revenue: $0.00Net Income: -$590294.00EPS: $-0.01View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$0.02+0.00%$841,406 #2

Algernon Pharmaceuticals Inc.

$0.43+0.00%$1.5M #3

Appili Therapeutics Inc.

$0.01-9.09%$1.3M #4

Strainsforpains, Inc.

$0.16+0.00%$1.9M #5

Galera Therapeutics, Inc.

$0.09+8.24%$7.0M #6

Health Sciences Group, Inc.

$0.00+0.00%$1.9M

股票表现

1D+0.00%

1W+0.00%

1M-44.74%

3M-56.70%

YTD-44.00%

1Y-4.55%

5Y-97.59%

关于 Agentix Corp.

CEORiazul Huda

IPO DateAug 21, 2015

Employees3

CountryUS

Websiteagentixcorp.com

Agentix Corp. a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two pr…

Biotechnology HealthcareOTCUS

关于股票概览与关键数据

Agentix Corp.（AGTX）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 21, 2015 在 OTC 上市。截至最近交易日，AGTX 股价为 $0.02，市值约为 $841,406。过去12个月累计回报 -4.55%，年初至今回报 -44.00%。

2025 财年 Agentix Corp. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Agentix Corp.（AGTX）股价为 $0.02，在 OTC 上市，52周区间为 $0.02 – $0.06。

AGTX 最新股价AGTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 15, 2026本内容不构成投资建议